Summary:
The purpose of the research study is to look at how effective and safe an investigational medication is when it is given to subjects who have celiac disease. The study will include people who have been diagnosed with celiac disease and have been on a gluten-free diet for 12 months or more before study entry.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have had biopsy proven celiac disease and positive serology test results for 12 months or more before study entry
•
Have been on a gluten-free diet for 12 months or more before study entry
•
Be experiencing symptoms when exposed to gluten
•
Have positive serum anti-tTG (IgA or IgG) or DGP (IgA or IgG) antibodies at screening
•
Be willing to maintain your current diet for the duration of the study
•
Satisfy other inclusion criteria